Insight Molecular Diagnostics Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-13.3M | $-14.8M | $1.6M | $2.0M |
| Jun 2022 | $-11.2M | $-12.4M | $1.1M | $2.2M |
| Sep 2022 | $-11.4M | $-12.3M | $859.0K | $3.2M |
| Dec 2022 | $-9.6M | $-10.5M | $802.0K | $2.6M |
| Mar 2023 | $-8.3M | $-8.3M | — | $834.0K |
| Jun 2023 | $-6.8M | $-6.8M | — | $834.0K |
| Sep 2023 | $-3.8M | $-3.8M | — | $608.0K |
| Dec 2023 | $-4.4M | $-4.4M | — | $484.0K |
| Mar 2024 | $-3.8M | $-3.9M | $24.0K | $418.0K |
| Jun 2024 | $-6.0M | $-6.2M | $191.0K | $386.0K |
| Sep 2024 | $-5.5M | $-5.6M | $87.0K | $450.0K |
| Dec 2024 | $-5.4M | $-5.6M | $214.0K | $499.0K |
| Mar 2025 | $-5.8M | $-6.1M | $307.0K | $473.0K |
| Jun 2025 | $-6.2M | $-6.5M | $349.0K | $504.0K |
| Sep 2025 | $-4.6M | $-5.7M | $1.1M | $521.0K |
| Dec 2025 | $-5.5M | $-7.0M | $1.5M | $721.0K |
| Mar 2026 | $-7.6M | $-8.3M | $613.0K | $615.0K |
| Jun 2026 | $-9.3M | $-10.0M | $779.0K | $661.0K |